C289-0197 Screening compound: 10,11-diethoxy-N-(9-ethyl-9H-carbazol-3-yl)-5-oxo-7,8,12b,13-tetrahydro-5H-6-azatetraphene-13-carboxamide

C289-0197 Screening compound: 10,11-diethoxy-N-(9-ethyl-9H-carbazol-3-yl)-5-oxo-7,8,12b,13-tetrahydro-5H-6-azatetraphene-13-carboxamide
C289-0197 Screening compound: 10,11-diethoxy-N-(9-ethyl-9H-carbazol-3-yl)-5-oxo-7,8,12b,13-tetrahydro-5H-6-azatetraphene-13-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C289-0197
10,11-diethoxy-N-(9-ethyl-9H-carbazol-3-yl)-5-oxo-7,8,12b,13-tetrahydro-5H-6-azatetraphene-13-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C289-0197

Molecular Formula

C36H35N3O4 (C36 H35 N3 O4)

Compound Name

10,11-diethoxy-N-(9-ethyl-9H-carbazol-3-yl)-5-oxo-7,8,12b,13-tetrahydro-5H-6-azatetraphene-13-carboxamide

IUPAC name

1011-diethoxy-N-(9-ethyl-9H-carbazol-3-yl)-5-oxo-7812b13-tetrahydro-5H-6-azatetraphene-13-carboxamide

SMILES

CCn1c(ccc(NC(C(C2N3CCc(cc4OCC)c2cc4OCC)c(cccc2)c2C3=O)=O)c2)c2c2c1cccc2

InChI

InChI=1S/C36H35N3O4/c1-4-38-29-14-10-9-11-24(29)28-20-23(15-16-30(28)38)37-35(40)33-25-12-7-8-13-26(25)36(41)39-18-17-22-19-31(42-5-2)32(43-6-3)21-27(22)34(33)39/h7-16,19-21,33-34H,4-6,17-18H2,1-3H3,(H,37,40)

InChI Key

YWWQNGSPFQKRIN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14741061

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

573.69

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.852

Distribution Coefficient, logD

5.852

Water Solubility, LogSw

-5.75

Polar Surface Area

54.158

Acid Dissociation Constant (pKa)

10.87

Base Dissociation Constant (pKb)

-0.72

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

27.80

C289-0197 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

DGK Inhibitors Library (10558 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with C289-0197 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C289-0197?
Check Price and Availability of C289-0197, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C289-0197 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C289-0197
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C289-0197
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C289-0197 available by request